Irina S Barequet1, Tzukit Zehavi-Dorin2, Nirit Bourla2, Ilia Tamarin3, Joseph Moisseiev2, Ophira Salomon3. 1. Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel - Aviv University, Tel Hashomer, Israel. ibarequet@yahoo.com. 2. Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel - Aviv University, Tel Hashomer, Israel. 3. Institute of Thrombosis & Hemostasis, Sheba Medical Center, Sackler Faculty of Medicine, Tel - Aviv, University, Tel Hashomer, Israel.
Abstract
PURPOSE: To evaluate the safety of phacoemulsification of cataract in patients taking new oral anticoagulants (NOACs). METHODS: In a prospective case series, consecutive patients on NOACs (dabigatran, rivaroxaban, or apixaban) who were referred for uncomplicated cataract surgery to the eye institute underwent a thorough ophthalmological and hematological evaluation. Rivaroxaban and apixaban anti-factor Xa tests, and diluted thrombin time for dabigatran, were used for monitoring anticoagulation levels in blood. Blood was drawn for these tests just prior to surgery and at a peak level of the drug at about 4 h post-surgery (2 h after the drug was given). All surgeries were videotaped and patients were examined at 1 and 7 days after the operation. The main outcome measures included assessment of intra-operative, postoperative ocular bleeding, and other related complications. RESULTS: Thirty-five eyes of 25 unrelated patients ranging in age from 63 to 92 years (mean 77.6 years) underwent phacoemulsification. Intra-operative bleeding was observed in 5 eyes from the conjunctiva or limbus at the main incision site. No intraocular bleeding occurred. No hemorrhagic complications were observed during the 1-week follow-up. According to anti-factor Xa levels prior to surgery and following surgery, 85% of the patients were on therapeutic levels of NOACs. CONCLUSIONS: Clear corneal incision phacoemulsification performed under topical anesthesia can be safely performed in simple cases of cataract without discontinuing NOAC treatment.
PURPOSE: To evaluate the safety of phacoemulsification of cataract in patients taking new oral anticoagulants (NOACs). METHODS: In a prospective case series, consecutive patients on NOACs (dabigatran, rivaroxaban, or apixaban) who were referred for uncomplicated cataract surgery to the eye institute underwent a thorough ophthalmological and hematological evaluation. Rivaroxaban and apixaban anti-factor Xa tests, and diluted thrombin time for dabigatran, were used for monitoring anticoagulation levels in blood. Blood was drawn for these tests just prior to surgery and at a peak level of the drug at about 4 h post-surgery (2 h after the drug was given). All surgeries were videotaped and patients were examined at 1 and 7 days after the operation. The main outcome measures included assessment of intra-operative, postoperative ocular bleeding, and other related complications. RESULTS: Thirty-five eyes of 25 unrelated patients ranging in age from 63 to 92 years (mean 77.6 years) underwent phacoemulsification. Intra-operative bleeding was observed in 5 eyes from the conjunctiva or limbus at the main incision site. No intraocular bleeding occurred. No hemorrhagic complications were observed during the 1-week follow-up. According to anti-factor Xa levels prior to surgery and following surgery, 85% of the patients were on therapeutic levels of NOACs. CONCLUSIONS: Clear corneal incision phacoemulsification performed under topical anesthesia can be safely performed in simple cases of cataract without discontinuing NOAC treatment.
Authors: Andrzej Grzybowski; Francisco J Ascaso; Konrad Kupidura-Majewski; Mark Packer Journal: Curr Opin Ophthalmol Date: 2015-01 Impact factor: 3.761
Authors: David Garcia; John H Alexander; Lars Wallentin; Daniel M Wojdyla; Laine Thomas; Michael Hanna; Sana M Al-Khatib; Paul Dorian; Jack Ansell; Patrick Commerford; Greg Flaker; Fernando Lanas; Dragos Vinereanu; Denis Xavier; Elaine M Hylek; Claes Held; Freek W A Verheugt; Christopher B Granger; Renato D Lopes Journal: Blood Date: 2014-10-15 Impact factor: 22.113
Authors: Cyril Meillon; Pierre Henry Gabrielle; Maxime Luu; Ludwig S Aho-Glele; Alain M Bron; Catherine Creuzot-Garcher Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-01-23 Impact factor: 3.117
Authors: Joanne Katz; Marc A Feldman; Eric B Bass; Lisa H Lubomski; James M Tielsch; Brent G Petty; Lee A Fleisher; Oliver D Schein Journal: Ophthalmology Date: 2003-09 Impact factor: 12.079